# An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

> **NCT00739739** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 161 (actual)

## Conditions studied

- Interstitial Cystitis
- Painful Bladder Syndrome

## Interventions

- **DRUG:** PD 0299685 at 15mg BID
- **DRUG:** PD 0299685 at 30mg BID
- **DRUG:** placebo for PD 0299685

## Key facts

- **NCT ID:** NCT00739739
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2011-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739739, "An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00739739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*